
Company Info
Year Established2015
Ticker
PROK
Exchange
NASDAQ
Contacts
Bruce Culleton, MDCEO
Nikhil Pereira-Kamath
CBO
James Coulston, CPA
CFO
Todd C. Girolamo, JD, MBA
CLO
Company Description
ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease, with the potential to preserve kidney function and change patients' lives.